TFF Pharmaceuticals will terminate employees and cease operations, appointing Craig R. Jalbert as the new CEO.Quiver AI SummaryTFF Pharmaceuticals, Inc. announced the termination of its employees and plans...
Issued on behalf of BioVaxys Technology Corp. VANCOUVER – USA News Group – In the field of medicine, many...
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of TFF Pharmaceuticals, Inc. ("TFF" or the "Company") (NASDAQ: TFFP). Such...
TFFP earnings call for the period ending June 30, 2022.
FORT WORTH, Texas, May 20, 2022 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on...
TFFP earnings call for the period ending March 31, 2022.
Announced Collaboration with Catalent to Further Expand Thin Film Freezing Applications with a Focus on Biologic Drug Development Announced Second CRADA...
Thin Film Freezing Technology Co-Inventor Dr. Robert O. Williams III to Deliver Platform Presentation of Data on Stabilizing and Delivering Antivirals,...
Company conference call and webcast at 4:30 PM ET...